The FDA Oncologic Drugs Advisory Committee July 17 recommended against approval of a Blenrep-based regimen for the treatment of relapsed or refractory multiple myeloma, citing unacceptable rates of ocular toxicity and overall poor tolerability of the drug.
NIH has announced that it will no longer be issuing Notices of Funding Opportunities exclusively supporting animal models.
President Trump said he would impose tariffs on pharmaceutical products and semiconductors as soon as Aug. 1.
The Centers for Medicare & Medicaid Services published a proposed rule, which it says aligns with Trump’s “Big Beautiful Bill.”
The Centers for Medicare & Medicaid Services issued a proposed rule that would update Medicare payment policies and rates for hospital outpatient departments and ambulatory surgical centers, or ASCs, for calendar year 2026.
Monica L. Baskin joined VCU Massey Comprehensive Cancer Center as deputy director of research.
Jill S. Barnholtz-Sloan was appointed chief administrative officer and associate director for research administration at Winship Cancer Institute of Emory University, effective July 21.
N. Lynn Henry was named associate director for community outreach and engagement at the University of Michigan Rogel Cancer Center.
Christopher Panczner was appointed CEO of the New York Proton Center, the state’s first and only proton radiation therapy center.
Elbert Y. Kuo, a thoracic surgeon who specializes in minimally invasive techniques, has joined Baptist MD Anderson Cancer Center as head of the Division of Surgery and surgeon-in-chief.
